Annual Shareholders Equity
$51.06 M
+$19.23 M+60.42%
December 31, 2023
Summary
- As of February 7, 2025, DMAC annual stockholders equity is $51.06 million, with the most recent change of +$19.23 million (+60.42%) on December 31, 2023.
- During the last 3 years, DMAC annual shareholders equity has risen by +$25.04 million (+96.27%).
- DMAC annual shareholders equity is now at all-time high.
Performance
DMAC Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$47.96 M
-$5.45 M-10.20%
September 30, 2024
Summary
- As of February 7, 2025, DMAC quarterly stockholders equity is $47.96 million, with the most recent change of -$5.45 million (-10.20%) on September 30, 2024.
- Over the past year, DMAC quarterly shareholders equity has dropped by -$7.67 million (-13.78%).
- DMAC quarterly shareholders equity is now -19.72% below its all-time high of $59.74 million, reached on June 30, 2023.
Performance
DMAC Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
DMAC Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +60.4% | -13.8% |
| 3 y3 years | +96.3% | +2.0% |
| 5 y5 years | +199.9% | +2.0% |
DMAC Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +60.4% | -19.7% | +77.5% |
| 5 y | 5-year | at high | +570.3% | -19.7% | +529.7% |
| alltime | all time | at high | +3437.3% | -19.7% | +3235.1% |
DiaMedica Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $47.96 M(-10.2%) |
| Jun 2024 | - | $53.41 M(+15.2%) |
| Mar 2024 | - | $46.35 M(-9.2%) |
| Dec 2023 | $51.06 M(+60.4%) | $51.06 M(-8.2%) |
| Sep 2023 | - | $55.63 M(-6.9%) |
| Jun 2023 | - | $59.74 M(+121.1%) |
| Mar 2023 | - | $27.02 M(-15.1%) |
| Dec 2022 | $31.83 M(-27.7%) | $31.83 M(-9.3%) |
| Sep 2022 | - | $35.08 M(-7.0%) |
| Jun 2022 | - | $37.72 M(-7.5%) |
| Mar 2022 | - | $40.77 M(-7.4%) |
| Dec 2021 | $44.02 M(+69.2%) | $44.02 M(-6.4%) |
| Sep 2021 | - | $47.04 M(+131.5%) |
| Jun 2021 | - | $20.32 M(-12.2%) |
| Mar 2021 | - | $23.14 M(-11.0%) |
| Dec 2020 | $26.01 M(+241.5%) | $26.01 M(-12.6%) |
| Sep 2020 | - | $29.76 M(+164.0%) |
| Jun 2020 | - | $11.27 M(-15.4%) |
| Mar 2020 | - | $13.32 M(+74.9%) |
| Dec 2019 | $7.62 M(-55.3%) | $7.62 M(-21.5%) |
| Sep 2019 | - | $9.70 M(-17.1%) |
| Jun 2019 | - | $11.70 M(-15.8%) |
| Mar 2019 | - | $13.91 M(-18.3%) |
| Dec 2018 | $17.02 M(+2030.8%) | $17.02 M(+1167.4%) |
| Sep 2018 | - | $1.34 M(-8.3%) |
| Jun 2018 | - | $1.46 M(-69.1%) |
| Mar 2018 | - | $4.73 M(+492.4%) |
| Dec 2017 | $799.00 K(-28.1%) | $799.00 K(-2685.8%) |
| Sep 2017 | - | -$30.90 K(-104.2%) |
| Jun 2017 | - | $731.90 K(>+9900.0%) |
| Mar 2017 | - | $5300.00(-99.5%) |
| Dec 2016 | $1.11 M(-190.1%) | $1.11 M(-31.3%) |
| Sep 2016 | - | $1.62 M(-255.6%) |
| Jun 2016 | - | -$1.04 M(+2.6%) |
| Mar 2016 | - | -$1.01 M(-17.8%) |
| Dec 2015 | -$1.23 M | -$1.23 M(+7.6%) |
| Sep 2015 | - | -$1.15 M(+21.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | -$940.10 K(-31.8%) |
| Mar 2015 | - | -$1.38 M(-10.0%) |
| Dec 2014 | -$1.53 M(-210.7%) | -$1.53 M(+115.2%) |
| Sep 2014 | - | -$710.80 K(-925.6%) |
| Jun 2014 | - | $86.10 K(-121.6%) |
| Mar 2014 | - | -$398.00 K(-128.8%) |
| Dec 2013 | $1.38 M(-39.0%) | $1.38 M(+164.8%) |
| Sep 2013 | - | $521.80 K(-67.2%) |
| Jun 2013 | - | $1.59 M(-55.7%) |
| Mar 2013 | - | $3.58 M(+58.2%) |
| Dec 2012 | $2.26 M(-62.0%) | $2.26 M(-56.0%) |
| Sep 2012 | - | $5.15 M(-8.0%) |
| Jun 2012 | - | $5.59 M(+23.6%) |
| Mar 2012 | - | $4.53 M(-24.1%) |
| Dec 2011 | $5.96 M(-30.0%) | $5.96 M(-20.2%) |
| Sep 2011 | - | $7.47 M(+20.0%) |
| Jun 2011 | - | $6.23 M(-16.8%) |
| Mar 2011 | - | $7.49 M(-12.2%) |
| Dec 2010 | $8.52 M(+713.6%) | $8.52 M(+20.8%) |
| Sep 2010 | - | $7.06 M(-13.3%) |
| Jun 2010 | - | $8.14 M(+1223.7%) |
| Mar 2010 | - | $615.30 K(-41.3%) |
| Dec 2009 | $1.05 M(-62.3%) | $1.05 M(-32.0%) |
| Sep 2009 | - | $1.54 M(-20.9%) |
| Jun 2009 | - | $1.95 M(-7.6%) |
| Mar 2009 | - | $2.11 M(-24.1%) |
| Dec 2008 | $2.78 M(-31.6%) | $2.78 M(-25.7%) |
| Sep 2008 | - | $3.74 M(+16.6%) |
| Jun 2008 | - | $3.21 M(-15.2%) |
| Mar 2008 | - | $3.78 M(-7.0%) |
| Dec 2007 | $4.06 M(+521.9%) | $4.06 M(-9.9%) |
| Sep 2007 | - | $4.51 M(+0.0%) |
| Jun 2007 | - | $4.51 M(-3.1%) |
| Mar 2007 | - | $4.65 M(+611.8%) |
| Dec 2006 | $653.60 K(+29.1%) | $653.60 K(+25.9%) |
| Sep 2006 | - | $519.10 K(+2.6%) |
| Dec 2005 | $506.10 K(-147.7%) | $506.10 K |
| Dec 2004 | -$1.06 M | - |
FAQ
- What is DiaMedica Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics annual shareholders equity year-on-year change?
- What is DiaMedica Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics quarterly shareholders equity year-on-year change?
What is DiaMedica Therapeutics annual stockholders equity?
The current annual shareholders equity of DMAC is $51.06 M
What is the all time high annual shareholders equity for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high annual stockholders equity is $51.06 M
What is DiaMedica Therapeutics annual shareholders equity year-on-year change?
Over the past year, DMAC annual stockholders equity has changed by +$19.23 M (+60.42%)
What is DiaMedica Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of DMAC is $47.96 M
What is the all time high quarterly shareholders equity for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high quarterly stockholders equity is $59.74 M
What is DiaMedica Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, DMAC quarterly stockholders equity has changed by -$7.67 M (-13.78%)